- Open
- 140.00
- High
- 142.00
- Low
- 137.00
- Close
- 137.90
- Change
- +0.00 (0.00%)
- Volume
- 22,367
| 20 Aug 2026 | 08:00:00 | Diaceutics and PCC launch NGS Concordance Study |
| 4 Aug 2026 | 14:00:01 | PDMR Shareholding/Share Incentive Plan & TVRs |
| 29 Jul 2026 | 07:00:01 | 75% ARR Growth Drives Revenue & Profit Visibility |
| 3 Jul 2026 | 07:00:02 | PDMR Shareholding/Share Incentive Plan and TVRs |
| 10 Jul 2026 | Annual Report and Accounts (to 2025-12-31) |
Diaceutics plc provides technology and solutions to the pharmaceutical and biotech industries, focusing on the commercialization of precision medicine diagnostics. The company offers data analytics, scientific, and advisory services through its platform, DXRX - The Diagnostics Network®. Diaceutics works with global pharmaceutical companies to enhance diagnostic pathways, ensuring that patients receive appropriate therapies based on biomarker testing. Its customer base includes many of the top pharmaceutical firms, and it operates in various international markets.
| 20 Aug 2026 | 08:00:00 | Diaceutics and PCC launch NGS Concordance Study |
| 4 Aug 2026 | 14:00:01 | PDMR Shareholding/Share Incentive Plan & TVRs |
| 29 Jul 2026 | 07:00:01 | 75% ARR Growth Drives Revenue & Profit Visibility |
| 3 Jul 2026 | 07:00:02 | PDMR Shareholding/Share Incentive Plan and TVRs |
| 10 Jul 2026 | Annual Report and Accounts (to 2025-12-31) |
Diaceutics plc provides technology and solutions to the pharmaceutical and biotech industries, focusing on the commercialization of precision medicine diagnostics. The company offers data analytics, scientific, and advisory services through its platform, DXRX - The Diagnostics Network®. Diaceutics works with global pharmaceutical companies to enhance diagnostic pathways, ensuring that patients receive appropriate therapies based on biomarker testing. Its customer base includes many of the top pharmaceutical firms, and it operates in various international markets.
| 25 Jun 2026 | 11:09:22 | Result of AGM |
| 15 Jan 2026 |
| AIM movers: Anglo Asian Mining copper production record and Tern loses investment |
| 25 Jun 2026 | 11:09:22 | Result of AGM |
| 15 Jan 2026 |
| AIM movers: Anglo Asian Mining copper production record and Tern loses investment |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £333m | -0.4% | |
| £285m | -0.0% | |
DXRXDiaceutics PLC | £117m | -0.0% |
| £41m | — | |
| £24m | +1.5% | |
| £16m | -0.4% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £333m | -0.4% | |
| £285m | -0.0% | |
DXRXDiaceutics PLC | £117m | -0.0% |
| £41m | — | |
| £24m | +1.5% | |
| £16m | -0.4% |
